AVIDITY BIOSCIENCES INC's ticker is RNA and the CUSIP is 05370A108. A total of 107 filers reported holding AVIDITY BIOSCIENCES INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $24,684 | -42.5% | 3,869 | 0.0% | 0.00% | -50.0% |
| Q2 2023 | $42,907 | -20.8% | 3,869 | +9.6% | 0.00% | -33.3% |
| Q1 2023 | $54,201 | -26.2% | 3,531 | +6.6% | 0.00% | 0.0% |
| Q4 2022 | $73,471 | +51.4% | 3,311 | +11.4% | 0.00% | +50.0% |
| Q3 2022 | $48,533 | +12.4% | 2,972 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $43,183 | +5.9% | 2,972 | +34.6% | 0.00% | +100.0% |
| Q1 2022 | $40,782 | -81.7% | 2,208 | -76.4% | 0.00% | -66.7% |
| Q4 2021 | $222,701 | -3.5% | 9,369 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $230,758 | -0.3% | 9,369 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $231,508 | +18.6% | 9,369 | +4.7% | 0.00% | 0.0% |
| Q1 2021 | $195,156 | +50.6% | 8,948 | +76.2% | 0.00% | +50.0% |
| Q4 2020 | $129,565 | -9.3% | 5,077 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $142,918 | – | 5,077 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 854,651 | $5,452,673 | 6.70% |
| COWEN AND COMPANY, LLC | 5,629,103 | $35,913,677 | 2.51% |
| 5AM Venture Management, LLC | 665,555 | $4,246,241 | 1.22% |
| RTW INVESTMENTS, LP | 6,689,789 | $42,680,854 | 0.90% |
| Casdin Capital, LLC | 1,250,000 | $7,975,000 | 0.88% |
| RA Capital Management | 6,416,998 | $40,940,447 | 0.81% |
| Cormorant Asset Management, LP | 1,762,115 | $11,242,294 | 0.66% |
| Boxer Capital, LLC | 1,121,327 | $7,154,066 | 0.38% |
| AtonRa Partners | 18,970 | $121,029 | 0.25% |
| Avoro Capital Advisors LLC | 2,510,000 | $16,013,800 | 0.25% |